An activist investor is turning up the heat on Saks Fifth Avenue owner Hudson’s Bay Co. Hedge fund Land and Buildings fired off its second letter in six weeks to the board of Hudson’s Bay on Monday, threatening to remove board members if the department store company doesn’t sell some of its prized real estate....
NYS Entity Status
NYS Filing Date
MAY 30, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - 24 SECOND AVENUE HOLDINGS LLC
AROUND THE WEB
- Activist investor turns up heat on owner of Saks Fifth Avenue
By Lisa Fickenscher - Monday Jul 31, 2017
- Boomer Esiason signs on to promote electric grill
By Claire Atkinson - Saturday Jul 29, 2017
Just as pro football camps open up to condition the players for the upcoming season, advertisers are also drafting their pitch persons. Our spies say former NY Jets quarterback and current WFAN radio host Boomer Esiason has been on many Madison Avenue top-pick lists. The sports broadcaster just signed with Johnsonville to help promote the...
- New Citizens Hold Their Heads High, 102 Floors Above New York
By LIZ ROBBINS - Tuesday Aug 15, 2017
Thirty immigrants were sworn in atop One World Trade Center, in a ceremony that featured a speech by the former U.S. attorney Preet Bharara.
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Jacoby Ellsbury is playing again, as Yankees hold their breath
By Dan Martin - Saturday Jun 24, 2017
Jacoby Ellsbury returned to game action on Saturday for the first time since suffering a concussion crashing into the center-field wall at Yankee Stadium on May 24. Ellsbury began a rehab assignment with Triple-A Scranton/Wilkes-Barre, playing center and batting second. He is scheduled to be the designated hitter for SWB on Sunday, then move to...
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]